相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells
Somya Ranjan Dash et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2022)
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
Subhajit Chatterjee et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
Saptarshi Sinha et al.
EXPERIMENTAL CELL RESEARCH (2022)
Repurposing quinacrine for treatment-refractory cancer
Derek B. Oien et al.
SEMINARS IN CANCER BIOLOGY (2021)
Anti-Cancer Agents in Medicinal Chemistry
Biswajit Das et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages
Rajalaxmi Pradhan et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2021)
PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)
Subhajit Chatterjee et al.
CELLULAR SIGNALLING (2021)
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis
Chinmayee Sethy et al.
VASCULAR PHARMACOLOGY (2021)
Signaling pathways governing breast cancer stem cells behavior
Kai Song et al.
STEM CELL RESEARCH & THERAPY (2021)
Tumour angiogenesis and c-Met pathway activation - implications in breast cancer
Suvradeep Mitra et al.
APMIS (2020)
Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells
Subhajit Chatterjee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Cancer stem cells contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary
Syama Krishnapriya et al.
ANGIOGENESIS (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Safety and Tolerability of c-MET Inhibitors in Cancer
Alberto Puccini et al.
DRUG SAFETY (2019)
Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation
Anmada Nayak et al.
CELLULAR ONCOLOGY (2019)
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
Mohamed Bouattour et al.
HEPATOLOGY (2018)
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Yazhuo Zhang et al.
MOLECULAR CANCER (2018)
Bioimpedimetric analysis in conjunction with growth dynamics to differentiate aggressiveness of cancer cells
Aditya Parekh et al.
SCIENTIFIC REPORTS (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Cancer stem cells (CSCs), cervical CSCs and targeted therapies
Ruixia Huang et al.
ONCOTARGET (2017)
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
Julia Tchou et al.
CANCER IMMUNOLOGY RESEARCH (2017)
SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis
Sumit Siddharth et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
ABT-888 and quinacrine induced apoptosis in metastatic breast cancer stem cells by inhibiting base excision repair via adenomatous polyposis coli
Sumit Siddharth et al.
DNA REPAIR (2016)
Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities
Ying Wang et al.
ONCOTARGET (2016)
Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases
Shunchao Yan et al.
DIAGNOSTIC PATHOLOGY (2015)
The clinical and functional significance of c-Met in breast cancer: a review
Colan M. Ho-Yen et al.
BREAST CANCER RESEARCH (2015)
cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?
Patricia B. Gaule et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-κB
Canhui Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells
G Taraboletti et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)